877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Kappa agonists, Antianginals

Categories

Analgesics (4)
Antiarrhythmic agents (4)
Antidepressants (4)
Antihypertensive agents (4)
Calcium channel blockers (4)
Delta-opioid agonists (4)
Dissociative drugs (4)
Drugs acting on the cardiovascular system (4)
Drugs acting on the nervous system (4)
Drugs acting on the respiratory system (4)
Euphoriants (4)
GABA receptor antagonists (4)
GABA receptor ligands (4)
Monoamine reuptake inhibitors (4)
Mu-opioid agonists (4)
Nociceptin receptor agonists (4)
Opioid receptor ligands (4)
Opioids (4)
Psychoactive drugs (4)
Psychopharmacology (4)
Respiratory system drug (4)
Serotonin-norepinephrine reuptake inhibitors (4)
Synthetic opioids (4)
Pharmaceuticals (1)

Suppliers

Sigma Aldrich (1)

levorphanol (77-07-6, 297-90-5)  
Levorphanol Tartrate  ·  Levorphan  ·  LevoDromoran
Levorphanol (INN; brand name Levo-Dromoran) is an opioid medication used to treat moderate to severe pain. It is one of four enantiomers of the compound racemorphan, and was first described in Germany in 1948 as an orally active, morphine-like analgesic. The drug has been in clinical use in the United States since 1953.
DEXTRORPHAN (297-90-5, 125-73-5)  
(+-)-17-Methylmorphinan-3-ol
Dextrorphan (DXO) is a psychoactive drug of the morphinan class which acts as an antitussive or cough suppressant and dissociative hallucinogen. It is the dextrorotatory-stereoisomer of racemorphan, the levo-half being levorphanol. Dextrorphan is produced by O-demethylation of dextromethorphan by CYP2D6.
Racemorphan (297-90-5)  
Racemorphan, or morphanol, is the racemic mixture of the two stereoisomers of 17-methylmorphinan-3-ol, each with differing pharmacology and effects: Dextrorphan - an antitussive and dissociative hallucinogen (NMDA receptor antagonist) Levorphanol - an opioid analgesic Racemorphan itself is under international control per the Single Convention on Narcotic Drugs 1961 and is therefore listed as a Schedule II Narcotic controlled substance in the US Controlled Substances Act 1970; it has an ACSCN of 9733 and in 2014 it had an aggregate annual manufacturing quota of zero. The salts in use are hydrobromide (free base conversion ratio 0.741), hydrochloride (0.876), and tartrate (0.632).
125-73-5 (125-73-5)  
Dextrorphan (DXO) is a psychoactive drug of the morphinan class which acts as an antitussive or cough suppressant and dissociative hallucinogen. It is the dextrorotatory-stereoisomer of racemorphan, the levo-half being levorphanol. Dextrorphan is produced by O-demethylation of dextromethorphan by CYP2D6.

Related Results:
UNII-37420PJU4M (32634-95-0)  
17-acetoxy-6-methylene-4-pregnene-3,20-dione  ·  17 alpha acetoxy-6-methylene-4-pregnene-3,20-dione  ·  VP-2
Pregneninolone (434-03-7)  
Ethisterone  ·  Anhydrohydroxyprogesterone  ·  17 alpha Ethynyltestosterone
Aethisteron (434-03-7)  
Ethisterone  ·  Pregneninolone  ·  Anhydrohydroxyprogesterone
17-Hydroxypregnenolone (387-79-1)  
Hydroxypregnenolone  ·  17-Hydroxypregnenolone, (3beta,13alpha,17alpha)-Isomer  ·  17-Hydroxypregnenolone, (3alpha)-Isomer
17α-Hydroxypregnenolone is a pregnane (C21) steroid that is obtained by hydroxylation of pregnenolone at the C17α position. This step is performed by the mitochondrial cytochrome P450 enzyme 17α-hydroxylase (CYP17A1) that is present in the adrenal and gonads. Peak levels are reached in humans at the end of puberty and then decline.
SPIRADOLINE (87151-85-7)  
Spiradoline (U-62066) is a drug which acts as a highly selective κ-opioid agonist. It has analgesic, diuretic and antitussive effects, and produces subjective effects in animals similar to those of ketazocine and alazocine. The main effect in humans is sedation, along with analgesic and diuretic effects, but significant side effects such as dysphoria and hallucinations have stopped it from being used clinically.
Skf 83566 (94344-79-3, 99295-33-7)  
SK and F-83566  ·  1H-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-  ·  7-bromo-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine
ciglitazone (74772-77-3)  
5-(4-(1-methylcyclohexylmethoxy)benzyl)thiazolidine-2,4-dione  ·  ADD-3878  ·  ciglitizone
Ciglitazone (INN) is a thiazolidinedione. Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class. Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones.
spiperone (749-02-0)  
Spiroperidol  ·  Spiroperone
Spiperone (Spiroperidol; brand name: Spiropitan (JP)) is a typical antipsychotic and research chemical belonging to the butyrophenone chemical class. It is licensed for clinical use in Japan as a treatment for schizophrenia. Additionally, spiperone was identified by compound screening to be an activator of Ca2+ activated Cl− channels (CaCCs), thus a potential target for therapy of cystic fibrosis.
ALPHA-PHELLANDRENE (4221-98-1, 1329-99-3, 99-83-2, 34448-33-4)  
alpha phellandrene, (S+)-isomer  ·  alpha phellandrene, (R)-isomer  ·  5-isopropyl-2-methyl-1,3-cyclohexadiene
Phellandrene is the name for a pair of organic compounds that have a similar molecular structure and similar chemical properties. α-Phellandrene and β-phellandrene are cyclic monoterpenes and are double-bond isomers. In α-phellandrene, both double bonds are endocyclic and in β-phellandrene, one of them is exocyclic.
3,20-Allopregnanedione (566-65-4)  
5alpha-Pregnane-3,20-dione  ·  3,20-Allopregnanedione, (5beta,13alpha,17alpha)-Isomer  ·  5 alpha-Pregnane-3,20-dione
QUINPIROLE (74196-92-2, 80373-22-4)  
Quinpirole is a psychoactive drug and research chemical which acts as a selective D2 and D3 receptor agonist. It is used in scientific research. Quinpirole has been shown to increase locomotion and sniffing behavior in mice treated with it.
1077-27-6 (1077-27-6, 62-46-4)  
Lipoic Acid  ·  alpha Lipoic Acid  ·  Thioctic Acid
Skf-81297 (71636-61-8)  
SKF 81297  ·  SK and F 81297  ·  SK and F-81297
SKF-81,297 is a synthetic drug of the benzazepine chemical class that acts as a selective dopamine D1/D5 receptor full agonist, and produces a characteristic stimulant-like pattern of anorexia, hyperactivity and self-administration in animals. This profile is shared with several related drugs such as 6-Br-APB and SKF-82,958, but not with certain other D1 full agonists such as A-77,636, reflecting functional selectivity of D1 activation. Newer findings reveal that SKF-81,297 additionally acts as a partial agonist at D1-D2 receptor heteromers.
Related searches
Kappa agonists
Antianginals
Next Page >